What does Bluestem Capital invest in?
Bluestem Capital invests most often at Series A and Venture (80% of the rounds on record), in sectors such as Social and Social Network.
United States · Investor
Filed with the SEC to raise a fund in May 2026, closing $1M. Last cheque observed Oct 2019.
QuietNew fund $545K, May 2026Private equity
11 rounds on record
Mostly Series A and Venture: 80% of its rounds
Sole investor in 2 rounds, median $1.0M
Filed 6 private fund offerings with the SEC, the most recent in 2023-04From their own website
Every round we can evidence, newest first11 appearances
1 round
1 round
1 round
1 round
3 rounds
1 round
1 round
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
Named by the firm itself, on a filing, its Form ADV or its company registration8 named
We also hold 15 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
From the firm's own filings with the SEC, which it must file accurately by law
From their own portfolio page (on their website)
LENTECHSOrasis PharmaceuticalsShoulder Innovations,SpringCMSydnexisZerigo HealthContinental Realty AdvisorsInSet™ glenoid designNewtonSYNQ3Solarity by EDCOSurface PharmaceuticalsVirtual Incision CorporationVirun
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The investors most often in the same rounds as Bluestem Capital. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Bluestem Capital put money into.
Bluestem Capital invests most often at Series A and Venture (80% of the rounds on record), in sectors such as Social and Social Network.
11 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2019.
Its most recent investments on record: Clarify Medical (Series A, Oct 2019), Tear Film (Series B, May 2018) and Tear Clear (Series A, May 2017).
The median round it joins is $13M.
Rarely, if at all: none of its 11 investments on record names it as the lead.
Most of the companies it backs are in the United States (100%).
No investments in the last 12 months; the latest was in Oct 2019.
Most often PrairieGold Venture Partners (2 rounds together) and Visionary Ventures Fund (2 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it